MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

500316

Report Date :

26.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

SMRUTHI ORGANICS LIMITED

 

 

Registered Office :

165 – A, Balaji Bhavan, 1st Floor, Railway Lines, Solapur – 413001, Maharashtra

Tel. No.:

91-217-2310268

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

11.07.1989

 

 

Com. Reg. No.:

11-052562

 

 

Capital Investment / Paid-up Capital :

INR 38.154 Million

 

 

CIN No.:

[Company Identification No.]

L24119PN1989PLC052562

 

 

IEC No.:

[Import-Export Code No.]

3192002808

 

 

TIN No:

27190386146

 

 

GSTN :

[Goods & Service Tax Registration No.]

27AACCS5562Q1ZO

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AACCS5562Q

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer of Bulk Drugs, Drug Intermediates, Fine Chemicals and Specialty chemicals. (Registered Activity)

 

 

No. of Employees :

182 (Approximately)

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the 1989 and it is a manufacturer and seller of bulk drugs Intermediates.

 

As per the financials of March 2017, the company has registered a growth of 9.33% in its revenue as compared to its previous year revenue and has reported average profit margin of 2.08%.

 

Rating takes into consideration the company’s established track record of business operations marked by sound net worth along with comfortable debt protection metrics and decent liquidity position.

 

Share are quoted high Stock Exchange. (Share are trader at a price of INR 97 against its face value of INR 10)

 

As per unaudited quarterly financials of December 2017, the company has achieved a revenue of INR 216.48 million and has reported good profit margin of 6.05%.

 

Payments terms seems to be usually correct.

 

In view of aforesaid, the subject can be considered for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term Rating (BB-) (Issuer Non-Cooperative)

Rating Explanation

Moderate risk of default.

Date

22.02.2018

 

Rating Agency Name

CRISIL

Rating

Short term Rating (A4) (Issuer Non-Cooperative)

Rating Explanation

Minimal degree of safety and very high credit risk.

Date

22.02.2018

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 26.03.2018

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Rakesh

Designation :

Sales Department

Contact No.:

91-22-24129211

Date :

24.03.2018

 

91-217-2310268/ 2620367/ 2310267)

 

 

LOCATIONS

 

Registered Office / Corporate Office :

165 – A, Balaji Bhavan, 1st Floor, Railway Lines, Solapur - 413001, Maharashtra, India

Tel. No.:

91-217-2310267/ 2310367

Fax No.:

91-217-2620268

E-Mail :

info@smruthiorganics.com

spr-smruthi2@sancharnet.in

eaga@smruthiorganics.com

changale@smruthiorganics.com

cs@smruthiorganics.com

investors@smruthiorganics.com

Website :

www.smruthiorganics.com

 

 

Mumbai Office :

108, Shivshakti Apartments, B - Wing, G. D. Ambedkar Road, Parel Village, Mumbai - 400012, Maharashtra, India

Tel. No.:

91-22-2415 5452/ 24129211

Fax No.:

91-22-2412 9211

E-Mail :

solbby@bom5.vsnl.net.in

 

Factory 1 :

Plot No. 273/274, M.I.D.C., Akkalkot Road, Solapur – 413006, Maharashtra, India

Tel. No.:

91-217-2651264

 

Factory 2 :

Plot No. A - 27, M.I.D.C. Area, Chincholi, Post Kondi, Taluka Mohol, District Solapur - 413255, Maharashtra, India

Tel. No.:

91-217-2257491/ 92/ 2357772/ 774775/ 2357771

Fax No.:

91-217-2357771

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Purushottam Mallayya Eaga

Designation :

Managing Director

Address :

Plot No 273/20, Dr. Antrilikar Nagar No 2, Hotgi Road, Solapur - 413003, Maharashtra, India

Date of Birth

02.04.1958

Qualification

M. Sc. (Org. Chem.)

Date of Appointment :

01.08.2010

DIN No.:

00033583

 

 

Name :

Mr. Jayant Hari Ranade

Designation :

Director

Address :

406, Vatvruksha Chs., Hari Krishna Pendse Lane, Brahmin Society, Naupada, Thane (West), Thane-400602, Maharashtra, India

Date of Appointment :

11.09.2006

DIN No.:

00004814

 

 

Name :

Mrs. Vaishnavi Purushottam Ega

Designation :

Director

Address :

Plot No 273/20, Dr. Antrilikar Nagar, No 2, Hotgi Road, Solapur- 413003, Maharashtra, India

Date of Birth

18.02.1962

Qualification

Bachelor of Arts

Date of Appointment :

09.09.1994

DIN No.:

00033669

 

 

Name :

Mr. Kashinath Revappa Dhole

Designation :

Director

Address :

224-17, Civil Lines, Gandhi Nagar, Solapur- 413001, Maharashtra, India

Date of Appointment :

27.09.2014

DIN No.:

01076675

 

 

Name :

Mr. Swapnil Purushotham Eaga

Designation :

Whole-Time Director

Address :

Plot No. 273/20, Dr. Antrolikar Nagar No -2, Hotgi Road, Solapur- 413003, Maharashtra, India

Date of Birth :

30.03.1984

Qualification :

B.S. (Chem) USA and MBA (Finance), Spain

Date of Appointment :

01.06.2015

PAN No.:

AAHPE9562C

DIN No.:

01241535

 

 

Name :

Dr. Rama Swamy Kanumala

Designation :

Director

Address :

Plot No.12, Sancharpuri Colony, Bowenpally, Secunderabad - 500011, Andhra Pradesh, India

Date of Appointment :

30.07.2012

DIN No.:

05273930

 

 

KEY EXECUTIVES

 

Name :

Mr. Swapnil Purushotham Eaga

Designation :

Chief Executive Officer

Address :

Plot No. 273/20, Dr. Antrolikar Nagar No -2, Hotgi Road, Solapur - 413003, Maharashtra, India

Date of Birth

30.03.1984

Qualification

B.S. (Chem) USA & MBA (Finance), Spain

Date of Appointment :

27.09.2014

PAN No.:

AAHPE9562C

 

Name :

Urvashi Dravendra Khanna

Designation :

Company Secretary

Address :

A - 103, Paradise Apartment, Shanti Nagar, Wagle Estate, Thane – 400604, Maharashtra, India

Date of Appointment :

06.08.2016

PAN No.:

BAPPK4198H

 

 

Name :

Mr. Rakesh

Designation :

Sales Department

 

 

MAJOR SHAREHOLDERS

 

As on DECEMBER 2017

 

Category of shareholder

Total nos. shares held

Shareholding as a % of total no. of shares

(A) Promoter & Promoter Group

2434666

63.81

 

(B) Public

1380764

36.19

 

Grand Total

3815430

100.00

 

 

 

Statement showing shareholding pattern of the Promoter and Promoter Group

 

Category of shareholder

No. of fully paid up equity shares held

Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2)

A1) Indian

0.00

Individuals/Hindu undivided Family

24125

0.63

EAGA PURUSHOTHAM MALAIAH

50

0.00

VAISHNAVI PURUSHOTHAM EAGA

25

0.00

YADAGIRI M EAGA

24050

0.63

Any Other (specify)

2410541

63.18

SMRUTHI CHEMICALS AND INTERMEDIATES LIMITED

82000

2.15

EAGA RAJAMOULI

9500

0.25

SMRUTHI PURUSHOTHAM EAGA

24000

0.63

E PURUSHOTTAM

1528510

40.06

SWAPNIL PURUSHOTHAM EAGA

190081

4.98

VAISHNAVI EAGA

576450

15.11

Sub Total A1

2434666

63.81

A2) Foreign

0.00

A=A1+A2

2434666

63.81

 

Statement showing shareholding pattern of the Public shareholder

 

Category & Name of the Shareholders

No. of fully paid up equity shares held

Shareholding % calculated as per SCRR, 1957 As a % of (A+B+C2)

B1) Institutions

0

0.00

B2) Central Government/ State Government(s)/ President of India

0

0.00

B3) Non-Institutions

0

0.00

Individual share capital upto INR 0.200 million

895203

23.46

Individual share capital in excess of INR 0.200 million

224095

5.87

Any Other (specify)

261466

6.85

Bodies Corporate

192281

5.04

Clearing Members

1876

0.05

NRI

40975

1.07

Bodies Corporate

240

0.01

Investor Education and Protection Fund

26094

0.68

Sub Total B3

1380764

36.19

B=B1+B2+B3

1380764

36.19

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Bulk Drugs, Drug Intermediates, Fine Chemicals and Specialty chemicals. (Registered Activity)

 

 

Products / Services :

NIC Code No.

Products/Services Description

3041

Bulk Drugs and Drug Intermediates (API Products)

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

182 (Approximately)

 

 

Bankers :

Banker Name :

State Bank of India

Branch :

Industrial Finance Branch, World Trade Centre, Mumbai - 400005, Maharashtra, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

  • Axis Bank Limited, 214/215, City Mall, Near Pune University, Pune-411007, Maharashtra, India

 

 

Facilities :

Secured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Axis Bank Term Loan

0.000

35.643

Deferral Sales Tax Loan PSI 1993 Scheme **

0.000

2.607

Deferral Sales Tax Loan PSI 1993 Expansion **

24.485

29.514

SBI – IFB – WCTL A/c

44.178

59.038

Axis Bank Limited – Car Loan

0.000

0.128

Short-term borrowings

 

 

Working Capital Loan S.B.I., IFB Mumbai and Solapur (Secured)

170.449

121.831

SBI IFB Mumbai PCFC Account

16.635

50.049

Total

255.747

298.810

Note: 

Long-term Borrowings

 

*1st mortgage / hypothecation charge on pari-passu basis with Axis Bank on Land and building and Plant and Machinery owned by the company situated at Plot No.273 and 274 MIDC, Akkalkot Road, Solapur 413006 and Plot No.A-27, MIDC Chincholi, Solapur- 413 255, First Charge on company's - Flat No 5, Rahul Neha Apartment Solapur , Flat No T/1 , Balaji Apartment Solapur, Holiday Resaurt at Plot No 31, Nakoda Constr. at village. Pakani Solapur, N.A. Plots GAT No. 230/2/B/2, 233/2/B, 231/2/B, 230/2/A/2 situated at Village Chincholi, Taluka Mohol, Dist. Solapur. First pari- passu charges on the above assest for Term Loan of INR 157.500 million from Axis Bank Pune. The Term Loan of Axis Bank INR 157.500 million is repayable in 60 months equal installment along with interest from 01.01.2013. Additional l collatoral Security of Mumbai Flat and eight Flats located at Solapur in the name of Company and one flat in the name of Mr. E.Purushotham, Managing Director of the Company in favour of State bank of India. Axis bank, Pune has sanctioned Term Loan-II of INR 35.000 miliion repayable in 28 months after One year Moratorium by various installments. State Bank of India has restructure the account and sanctioned INR 60.000 miilion Working Capital Term Loan repayable from Apr 2016 to Mar 2020 by various installments.

 

*Personal guarantee of Mr. E Purushotham , Managing Director and Mrs. E Vaishnavi Director.

 

**Deferred Sales Tax Loan is interest free and payable in yearly in 5 installment of each financial year after completion of 10 years and the final installment will due on 26.04.2022

 

Short-term borrowings

 

*1st registered mortgage / hypothecation charge on pari-passu basis with Axis Bank on Land and building and Plant and Machinery owned by the company situated at Plot No.273 and 274 MIDC, Akkalkot Road, Solapur 413006 and Plot No.A-27, MIDC Chincholi, Solapur- 413 255, First Charge on company's - Flat No 5, Rahul Neha Apartment Solapur, Flat No T/1, Balaji Apartment Solapur, Holiday Resaurt at Plot No 31, Nakoda Constr. at village. Pakani Solapur, N.A. Plots GAT No. 230/2/B/2, 233/2/B, 231/2/B, 230/2/A/2 situated at Village Chincholi, Taluka Mohol, Dist. Solapur. Company has also offered additional collatoral Security of Mumbai Flat and eight Flats located at Solapur in the name of Company and one flat in the name of Mr. E. Purushotham, Managing Director of the Company in favour of State bank of India as per revised sanction letter. During the last year State Bank of India has restructuring of Working Capital Limit sanctioned INR 60.000 million repayable from Apr 2016 to Mar 2020 by various installments.

 

*Personal guarantee of Mr E Purushotham , Managing Director and Mrs. E Vaishnavi, Director

 

Auditors 1:

 

Name :

N.R. Waghchaure and Associates

Chartered Accountants

Address :

16-22, Royal Plaza, Behind Bhagwat Petrol Pump, Murarji Peth, Solapur – 413001, Maharashtra, India

Tel. No.:

91-217-2625054/ 2623170

Mobile No.:

91-9423590501

E-Mail :

Fcanrw1970@gmail.com

 

 

Auditors 2:

 

Name :

Ashok Madgundi and Company

Chartered Accountant

Address :

210/A/1, Sakhar Peth, Near Kanya Prashala, Solapur – 413005, Maharashtra, India

Tel. No.:

91-217-626540/620403

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Other Related Parties:

Smruthi Chemicals and Intermediates Limited

 

 

CAPITAL STRUCTURE

 

As on 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5000000

Equity Shares

INR 10/- each

INR 50.000 Million

5000000

Non-Convertible Cumulative Redeemable Preference Shares

INR 10/- each

INR 50.000 Million

 

 

 

INR 100.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3815430

Equity Shares

INR 10/- each

INR 38.154 Million

 

 

 

 

 

Details of Shareholders holding more than 5% shares in the Company

 

Name of Shareholder

Number of Shares

% holding

Mr. Eaga Purushotham

1528560

40.06

Mrs. Eaga Vaishnavi

576475

15.11

 


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

38.154

38.154

38.154

(b) Reserves & Surplus

284.590

268.740

256.515

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

322.744

306.894

294.669

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

82.134

126.930

170.083

(b) Deferred tax liabilities (Net)

2.005

0.000

0.000

(c) Other long term liabilities

20.008

187.861

176.547

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

104.147

314.791

346.630

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

187.084

185.350

232.855

(b) Trade payables

168.822

151.279

157.325

(c) Other current liabilities

65.859

69.596

57.429

(d) Short-term provisions

5.814

3.321

0.000

Total Current Liabilities (4)

427.579

409.546

447.609

 

 

 

 

TOTAL

854.470

1031.231

1088.908

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

297.286

322.413

353.135

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

12.981

10.861

10.793

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

8.234

3.435

0.493

(c) Deferred tax assets (net)

0.000

6.428

14.594

(d)  Long-term Loan and Advances

0.000

247.231

243.782

(e) Other Non-current assets

87.572

0.000

0.000

Total Non-Current Assets

406.073

590.368

622.797

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

194.438

193.477

178.330

(c) Trade receivables

210.756

192.854

216.768

(d) Cash and cash equivalents

16.202

16.268

16.918

(e) Short-term loans and advances

27.001

38.264

54.095

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

448.397

440.863

466.111

 

 

 

 

TOTAL

854.470

1031.231

1088.908

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

793.537

725.804

748.046

 

Other Income

9.760

4.493

1.649

 

TOTAL

803.297

730.297

749.695

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

491.245

449.342

474.528

 

Purchases of Stock-in-Trade

0.000

0.000

0.000

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(1.708)

(24.091)

56.066

 

Employees benefits expense

79.460

74.780

63.178

 

Other expenses

124.966

119.835

107.944

 

TOTAL

693.963

619.866

701.716

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

109.334

110.431

47.979

 

 

 

 

 

Less

FINANCIAL EXPENSES

43.741

51.227

56.507

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

65.593

59.204

(8.528)

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

39.660

43.299

48.038

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

25.933

15.905

(56.566)

 

 

 

 

 

Less

TAX

9.448

8.671

(18.430)

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

16.485

7.234

(38.136)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

214.398

202.173

257.658

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

Depreciation of earlier years

0.000

0.000

17.349

 

Income Tax Refund up to AY 11-12 Tax of the last years

0.000

(4.991)

0.000

 

Short Provision etc. in FY 15-16

0.635

0.000

0.000

 

Total

0.635

(4.991)

17.349

 

 

 

 

 

 

Balance Carried to the B/S

230.248

214.398

202.173

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

Export Earing

276.117

236.020

192.515

 

TOTAL EARNINGS

276.117

236.020

192.515

 

 

 

 

 

 

IMPORTS

 

 

 

 

Sales Commission

2.623

3.286

7.467

 

Travelling

0.000

0.000

0.096

 

Raw Material

186.544

160.597

194.615

 

TOTAL IMPORTS

189.167

163.883

202.178

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

4.32

1.90

10.00

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

78.693

135.180

85.274

Net cash flows from (used in) operations

NA

NA

NA

Net cash flows from (used in) operating activity

77.561

139.667

85.052

 

 

QUARTERLY RESULTS

 

Particulars

 

30.06.2017

(Unaudited)

30.09.2017

 (Unaudited)

31.12.2017

 (Unaudited)

 

1st  Quarter

2nd Quarter

3RD Quarter

Net Sales

174.780

271.580

216.480

Total Expenditure

156.530

249.790

185.660

PBIDT (Excl OI)

18.250

21.790

30.820

Other Income

1.500

0.290

3.250

Operating Profit

19.750

22.080

34.070

Interest

11.230

10.200

10.770

Exceptional Items

NA

NA

NA

PBDT

8.520

11.880

23.300

Depreciation

9.900

9.100

10.200

Profit Before Tax

(1.380)

2.780

13.100

Tax

NA

NA

NA

Provisions and contingencies

NA

NA

NA

Profit After Tax

(1.380)

2.780

13.100

Extraordinary Items

NA

NA

NA

Prior Period Expenses

NA

NA

NA

Other Adjustments

NA

NA

NA

Net Profit

(1.380)

2.780

13.100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

96.94

96.98

105.77

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

3.77

3.76

3.45

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

125.44

122.88

121.01

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.56

0.57

0.27

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.35

0.33

0.13

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.60

0.52

0.57

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.83

1.02

1.37

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

1.32

1.33

1.52

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.96

1.09

1.24

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

2.50

2.16

0.85

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

2.08

1.00

(5.10)

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

1.93

0.70

(3.50)

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

5.11

2.36

(12.94)

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.05

1.08

1.04

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.59

0.60

0.64

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.38

0.30

0.27

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

7.06

8.18

10.56

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.05

1.08

1.04

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

STOCK PRICES

 

Face Value

INR 10.00/-

Market Value

INR 97.00/-

 


 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

38.154

38.154

38.154

Reserves & Surplus

256.515

268.740

284.590

Net worth

294.669

306.894

322.744

 

 

 

 

long-term borrowings

170.083

126.930

82.134

Short term borrowings

232.855

185.350

187.084

Total borrowings

402.938

312.280

269.218

Debt/Equity ratio

1.367

1.018

0.834

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

748.046

725.804

793.537

 

 

(2.973)

9.332

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

748.046

725.804

793.537

Profit (Loss)

(38.136)

7.234

16.485

 

(5.10%)

1.00%

2.08%

 

 

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last two/ three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 


OPERATIONAL PERFORMANCE/ STATE OF COMPANY'S AFFAIRS

 

During the year, total income of the Company was INR 803.297 Million as compared to INR 730.297 Million during previous year, registering an increase of 10%. The company stopped manufacturing and marketing of one low-margin products. The Company posted net profit of INR 16.485 million as against INR 7.234 million in the previous year. In addition to, operating level, the company's performance improved substantially primarily on account of reduction in prices of raw materials and overall improvement in plant productivity and efficiencies.

 

 

MANAGEMENT DISCUSSION AND ANALYSIS

 

BUSINESS OF THE COMPANY AND FUTURE OUTLOOK:

 

The company continues to be driven by focus on improving profitability. The company's product portfolio rationalization and marketing focus on high margin products, has delivered good results at the profitability level in the current financial year. Product portfolio rationalization had a good effect on sales, the impact on operating margin and bottom line is improved in the current financial year compared to the previous year.

 

The company has also had successes in reducing cost through process and operational improvement. The company's measures to reduce operating costs under taken on an ongoing basis in the current FY 2016- 17 have directly contributed to the bottom line. The company is increasing its efforts to work on cost reduction and is seeing good progress in this direction.

 

With the improvement in the company's financial performance, the company is expecting reduction in its cost of capital. Given no significant plans to raise additional debt, the company shall be able to improve its profitability.

 

The company is actively pursuing three key avenues for not only boosting growth in sales but also more importantly accelerating growth in profitability:

 

1. Volume Push: The addition of new customers over FY 2016-17 will enable the company to achieve significant volume growth of key products going forward. Any incremental volume growth over FY 2016-17 will contribute directly to the bottom line, thus taking the company in the direction of higher profitability.

 

2. Regulated Markets: The Company is poised to apply to European Directorate for Quality of Medicines (EDQM) for Certificate of Suitability (COS) for its key products. Upon successful approval from EDQM, the company shall be able to open up new markets like EU and allied markets such as Turkey and some Middle Eastern countries. The access to these markets will result in realization of higher margins due to premium pricing dynamics of these markets.

 

3. New Products: The Company is developing several new products to be launched through investments in internal as well as external R&D. Although the product pipeline has the potential to boost sales in the short to medium term, they are more likely to provide a robust base for long term growth of the company.

 

 

UNSECURED LOAN

 

PARTICULAINR

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Short-term borrowings

 

 

Unsecured Loans

 

 

Directors

13.470

13.470

Total

13.470

13.470

 

INDEX OF CHARGES

 

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G59386110

80013457

State Bank of India

15/02/2001

19/09/2017

-

438600000.0

Corporate Banking Branch, 214-215,City Mall Near Pune University, Ganesh Khind Road, Pune – 411007, Maharashtra,India

2

G62495338

10398153

Axis Bank Limited

17/12/2012

29/07/2015

14/11/2017

192500000.0

Industrial Finance Branch, World Trade Centre, Cuffe Parade, Mumbai – 400005, Maharashtra, India

3

B79652285

10044312

SBI FACTORS AND COMMERCIAL SERVICES (P) LIMITED

15/02/2007

23/07/2008

10/07/2013

547500000.0

102, 1st Floor, Oracle Point, Turner Road, (Gurunanak Road), Opposite Bandra Railway, Bandra, Mumbai – 400050, Maharashtra, India

 

 

CONTINGENT LIABILITIES:

 

a) While removing goods from our EOU to DTA unit, Excise & Custom duties discharged through Cenvat Account and not from PLA. Procedural laps. Appeal is filled with Additional Commissioner of Central Excise, Pune from the year 2007 to 2011 amounting to INR 5.744 million plus Interest.

b) While removing goods from our EOU to DTA unit, Excise & Custom duties discharged through Cenvat Account and not from PLA. Procedural laps. Appeal is filled with Additional Commissioner of Central Excise, Pune from the year 2007 to 2011 amounting to INR 5.744 million plus Interest.

c) Cenvat Credit is not considered by Central Excise Department (Preventive) against credit of raw material purchase which is under appeal with Tribunal Mumbai for F Y 2009-10 for INR 0.109 million.

d) Duty disputed on Clearance of goods from EOU, appeal filled with Commissioner of Central Excise Pune for the year 2013-14 amounting to INR 4.154 million plus Interest.

e) Duty disputed on clearance of goods, appeal to be filled with Commissioner of Central Excise Pune for the year 2014-15 amounting to INR 3.822 million plus Interest.

 

 

UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED AND NINE MONTHS DECEMBER 31, 2017

 

[INR IN MILLION]

 

PARTICULARS

3 Months

9 Months

 

31.12.2017

30.09.2017

31.03.2017

 

[Unaudited]

[Unaudited]

[Unaudited]

1. Income from Operations

 

 

 

Net Sales/income from operations

216.482

268.394

657.116

Other Operating Income

3.254

3.480

9.668

Total income from operations (net)

219.736

271.874

666.784

 

 

 

 

Expenses

 

 

 

Cost of materials consumed

148.383

154.313

420.562

Changes in inventories of finished goods. work-in-progress and stock in trade

(25.157)

30.501

(10.474)

Employee benefits expense

24.360

23.984

69.268

Depreciation and Amortization Expenses

10.200

9.100

29.200

Other Expenses

38.081

40.998

111.535

Finance Costs

10.774

10.198

32.202

Total expenses

206.641

269.094

652.293

Profit/ (Loss) from ordinary activities after finance cost but before exceptional items

13.095

2.780

14.491

Exceptional items

0.000

0.000

0.000

Profit/ (Loss) from ordinary activities before tax

13.095

2.780

14.491

Tax expenses

0.000

0.000

0.000

Net Profit / (Loss) from ordinary activities after tax

13.095

2.780

14.491

Extraordinary item (net of tax expense)

0.000

0.000

0.000

Net Profit / (Loss) for the period

13.095

2.780

14.491

Comprehensive Income

0.000

0.000

0.000

Net Profit/ (Loss) after taxes, minority interest and share of profit/(loss) of associates

13.095

2.780

14.491

 

 

 

 

Paid up equity share capital (Face Value of INR 10/-each)

38.154

38.154

38.154

Reserve excluding Revaluation Reserve as per Balance Sheet of previous accounting year

 

 

 

Earnings per share (before extraordinary items) of INR 10/- each (not annualized):

 

 

 

(a) Basic

3.43

0.73

3.80

(b) Diluted

3.43

0.73

3.80

 

 

Note:

 

  1. The entire operations of the Company constitute a single operating segment i.e. Bulk Drugs and Drug Intermediates. 
  2. Adjustment for deferred tax will be made in the last quarter of the financial year based on year end results. 
  3. Provision of Income Tax will be made in the last quarter of the current financial year. 
    4. Considering net profit of the Company for the quarter, Income Tax Provision has not been made. 
  4. The Statutory Auditor have carried out a limited review of the Un-audited financial results of the Company for the quarter and Nine Month ended 31st December, 2017. 
  5. The above financials were reviewed by the Audit Committee and Approved by the Board of Directors meeting held on 10th February 2018. 
  6. The financial results are prepared in accordance with the Indian Acounting Standards (IND AS) as prescribed under Section 133 of the Companies Act, 2013 and other recognized accounting practices and policies to the extent applicable. 
  7. There is no impact on net profit/loss, total comprehensive income or any other relevant financial items due to change in accounting policies. 
  8. Previous period's figures have been regrouped/rearranged wherever necessary to confirm to the current period's classification. 

 

 

FIXED ASSETS

  • Factory Land
  • Agriculture Land
  • Building
  • Furniture and Fixture
  • Computer
  • Ownership Flats
  • Electrical Installation/Equip.
  • Vehicles
  • Office Equipments
  • Laboratory Equipment
  • Plant and Machinery

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 65.13

UK Pound

1

INR 91.96

Euro

1

INR 80.34

 

 

INFORMATION DETAILS

 

Information Gathered by :

SLK

 

 

Analysis Done by :

VVK

 

 

Report Prepared by :

MTN

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.